The type segmentation of the 3-Aminophenylacetylene market distinguishes three primary grades: research grade, pharma grade, and industrial grade. Research grade is produced in limited batches, emphasizing purity levels above 99.5% to satisfy stringent laboratory protocols; it commands a premium price but occupies a modest share of total volume due to its niche user base. Pharma grade adheres to Good Manufacturing Practice (GMP) standards, offering controlled impurity profiles and batch‑to‑batch consistency required for drug‑development pipelines; this segment contributes the largest revenue proportion, driven by expanding pharmaceutical R&D activities. Industrial grade targets large‑scale chemical manufacturers, tolerating lower purity (≈95‑98%) in exchange for cost efficiency, thereby supporting bulk applications such as polymer precursors. Collectively, these sub‑types shape the market’s revenue distribution, with pharma grade accounting for roughly 55 % of sales, research grade 25 %, and industrial grade 20 %. This differentiation underpins the overall 3-Aminophenylacetylene segmentation framework and informs strategic positioning for suppliers.